Article
Two clinical phenotypes in polycythemia vera.
The New England journal of medicine - 28 Aug 2014
Spivak Jerry L, Considine Michael, Williams Donna M, Talbot Conover C, Rogers Ophelia, Moliterno Alison R, Jie Chunfa, Ochs Michael F
Abstract excerpt
BACKGROUND: Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ hematopoietic stem cells is unknown. METHODS: We analyzed gene expression in CD34+ peripheral-blood cells from 19 patients with polycythemia vera, using oligonucleotide microarray technology after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
